- Home
- » Tags
- » Ozoralizumab
Top View
- WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
- Rhode Island M Edical J Ournal
- Prescrire's Contribution to the WHO Consultation on List 105 Of
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Failed Initial Tumor Necrosis Inhibitor (Tnfi) Therapy – What Next for Rheumatoid Arthritis Patients?
- Albumin As a Delivery Carrier for Rheumatoid Arthritis
- Older Americans, Please See Medi- See Please Ing Older Americans, Ameri- for Older Cines in Development
- Present Situation and Problems of Clinical Trials for Inflammatory Bowel Disease in Japan
- WO 2013/087911 Al 20 June 2013 (20.06.2013) P O P C T
- Biotechnology Presented by America’S Biopharmaceutical Research Companies
- Beyond Anti-Tnfs
- Nanobodies As Therapeutics: Big Opportunities for Small Antibodies
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Application No. AU 2020205207 Al (19) AUSTRALIAN PATENT OFFICE
- Gm, Ke, Lr, Ls, Mw, Mz, Na, Rw, Sd, Sl, St, Sz, Tz, Ug, Zm, Zw
- Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
- (INN) for Biological and Biotechnological Substances
- Antibodies[Version 1; Peer Review: 2 Approved]
- Targeted Immunomodulatory Therapy: an Overview
- Compounds and Methods for Treating Inflammatory
- WHO Drug Information Vol
- (12) 按照专利合作条约所公布的国际申请w O 2016/050208
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- Quantify RA Clinical Outcomes Database